We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fibroblast growth factor 23 and uremic vascular calcification: is it time to escalate from biomarker status to pathogenic agent?
- Authors
Moe, Orson W; Kuro-o, Makoto
- Abstract
Although epidemiologic associations have been informative, the elucidation of the role of fibroblast growth factor 23 (FGF23) in chronic kidney disease (CKD) requires testing with robust experimental models. Jimbo et al. used animal and cell-culture models to query whether FGF23 is a direct 'vasculotoxin.' We discuss the interpretation of their findings. At this juncture, much remains unanswered about the significance of FGF23 elevation in CKD.
- Subjects
KIDNEY disease treatments; FOCAL segmental glomerulosclerosis; FIBROBLAST growth factors; CELL culture; BIOMARKERS
- Publication
Kidney International, 2014, Vol 85, Issue 5, p1022
- ISSN
0085-2538
- Publication type
Article
- DOI
10.1038/ki.2013.471